Clinical Trial Update: A Study Intravitreal THN391 in Diabetic Macular Oedema Secondary to Non-Proliferative Diabetic Retinopathy. [Phase 1]

View source ↗

Summary

A Phase 1 intravitreal study of THN391 for diabetic macular edema due to non-proliferative diabetic retinopathy is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Macular Edema
• Diabetic Retinopathy

Drugs mentioned

• THN391

Snippet

Sponsor: Therini Bio Pty Ltd | Conditions: Diabetic Macular Edema, Diabetic Retinopathy | Phase 1 | Status: RECRUITING